what's the buzz.


Utilising a unique link between a survey of over 60,000 people and a comprehensive mortality database, researchers at the University of Bergen, Norway, and the Institute of Psychiatry (IoP) at King’s College, London, found that over the four years following the survey, the mortality risk was increased to a similar extent in people who were depressed as in people who were smokers.
Study’s lead author Dr Robert Stewart has explained the possible reasons, saying: “Unlike smoking, we don’t know how causal the association with depression is but it does suggest that more attention should be paid to this link because the association persisted after adjusting for many other factors,” he said.
The study also showed that patients with depression face an overall increased risk of mortality, while a combination of depression and anxiety in patients lowers mortality.

Poor care worsens dementia patients’ condition
Britain’s Alzheimer’s Society has found that half of the patients come out of hospital in a worse condition. It was also found that one third are never able to return home and are sent to a nursing home instead.
Over three-quarters of relatives criticise the treatment patients receive in hospital, while one third have even made a formal complaint. The society says that poor care often causes dementia patients to stay in hospitals for weeks and months, much longer than necessary.
The latest report comes on the heels of another investigation, which revealed that almost 2,000 dementia patients were killed in a year by ‘chemical cosh’ drugs administered to them to keep them quiet.

Soon, an injectable vaccine to help kick the butt
Good news for smokers struggling to quit: an injectable vaccine has been developed that may help them kick the habit.
Smokers could soon have access to the vaccine following a deal between GlaxoSmithKline and Nabi Pharmaceuticals, the company that developed the drug.
The NicVAX vaccine creates anti-bodies that bind to nicotine molecules and stops them from entering the blood flowing into the brain, where the pleasurable sensation is created. Tests of the vaccine have shown that it can halve the number of smokers who go back to nicotine after trying to give it up.
The deal will see GSK paying 24 million pounds up front and 296 million pounds to Nabi. “If approved this technology could be a novel solution to help the millions of smokers who want to stop smoking and remain abstinent; a habit that is very well-documented to be very hard to stop permanently,” says Jean Stephenne, president of GSK's Biologicals division.

Beauty-conscious women use 515 chemicals a day
Beauty products such as lipstick, lotion, foundation, mascara add up to 515 chemicals on a woman’s face every day, says a study.
Charlotte Smith of deodorant firm Bionsen, which conducted the research, found that girls were using up to 13 products, most containing more than 20 ingredients.
Perfume fared the worst, containing a mixture of 250 components on average while some labels chose from 400 chemicals.
Lipstick was found consisting 33 elements, body lotion 32, mascara 29, and hand moisturiser 11. Experts linked some of the additives to cancer, hormone problems, skin conditions and allergies

Liked the story?

  • 0

    Happy
  • 0

    Amused
  • 0

    Sad
  • 0

    Frustrated
  • 0

    Angry